Clinical trial
Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel…
NCT00189696 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00189696 |
|---|---|
| Title | Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | YM060 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 12, 2015 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: